Oncology drugs

203 results

  • abecma

    (Idecabtagene Vicleucel)
    Celgene Corporation
    Abecma treats adult patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.
    Medication Details
    Drug Interactions

  • abraxane - paclitaxel injection, powder, lyophilized, for suspension

    (Paclitaxel)
    Abraxis Bioscience, Llc
    ABRAXANE treats metastatic breast cancer after prior chemotherapy failure, locally advanced or metastatic non-small cell lung cancer (first-line with carboplatin) in patients ineligible for surgery or radiation, and metastatic pancreatic adenocarcinoma (first-line with gemcitabine).
    Medication Details
    Drug Interactions

  • adcetris - brentuximab vedotin injection, powder, lyophilized, for solution

    (Brentuximab Vedotin)
    Seagen Inc.
    ADCETRIS treats classical Hodgkin lymphoma (untreated, consolidation, or relapsed), systemic and cutaneous anaplastic large cell lymphoma, CD30-expressing mycosis fungoides, peripheral T-cell lymphomas, and relapsed/refractory large B-cell lymphoma in adults; and high-risk cHL in pediatric patients 2 years and older.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • adstiladrin - nadofaragene firadenovec - vncg suspension

    (Nadofaragene Firadenovec-Vncg)
    Ferring Pharmaceuticals Inc.
    Adstiladrin treats adults with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ, with or without papillary tumors.
    Medication Details

  • akynzeo - netupitant and palonosetron capsule

    (Netupitant And Palonosetron)
    Helsinn Therapeutics (U.S.), Inc.
    AKYNZEO (palonosetron/netupitant) is used with dexamethasone in adults to prevent acute and delayed nausea and vomiting from cancer chemotherapy, including highly emetogenic regimens. Available as capsules for broad chemotherapy use and as an injection for highly emetogenic chemotherapy only.
    Medication Details
    Drug Interactions

  • alecensa - alectinib hydrochloride capsule

    (Alectinib Hydrochloride)
    Genentech, Inc.
    Alecensa treats adults with ALK-positive non-small cell lung cancer (NSCLC): as adjuvant therapy after resection of tumors ≥4 cm or node-positive, and for metastatic ALK-positive NSCLC. ALK-positive status must be confirmed by an FDA-approved test.
    Medication Details
    Drug Interactions

  • alunbrig - brigatinib tablet, film coated

    (Brigatinib)
    Takeda Pharmaceuticals America, Inc.
    Alunbrig treats adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
    Medication Details
    Drug Interactions

  • aphexda - motixafortide injection, powder, lyophilized, for solution

    (Motixafortide)
    Biolinerx Usa Inc
    Aphexda is used with filgrastim (G-CSF) to mobilize hematopoietic stem cells into the bloodstream for collection and autologous transplantation in patients with multiple myeloma.
    Medication Details

  • arimidex - anastrozole tablet

    (Anastrozole)
    Ani Pharmaceuticals, Inc.
    Arimidex is an aromatase inhibitor for postmenopausal women with breast cancer: adjuvant treatment of hormone receptor-positive early breast cancer; first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer; and second-line treatment of advanced breast cancer following tamoxifen therapy progression.
    Medication Details
    Drug Interactions

  • aromasin - exemestane tablet

    (Exemestane)
    Pharmacia & Upjohn Company Llc
    Aromasin treats estrogen-receptor positive early breast cancer in postmenopausal women switching from tamoxifen to complete five years of adjuvant hormonal therapy. Also indicated for advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.
    Medication Details
    Drug Interactions